Crewe Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4K | Hold |
82
| – | – | ﹤0.01% | 459 |
|
|
2025
Q1 | $10.5K | Sell |
82
-150
| -65% | -$19.2K | ﹤0.01% | 423 |
|
|
2024
Q4 | $30.7K | Hold |
232
| – | – | ﹤0.01% | 316 |
|
|
2024
Q3 | $33.8K | Sell |
232
-28
| -11% | -$4.08K | ﹤0.01% | 343 |
|
|
2024
Q2 | $35.7K | Hold |
260
| – | – | ﹤0.01% | 430 |
|
|
2024
Q1 | $35.7K | Hold |
260
| – | – | ﹤0.01% | 412 |
|
|
2023
Q4 | $35.3K | Buy |
260
+78
| +43% | +$10.6K | 0.01% | 141 |
|
|
2023
Q3 | $22.3K | Hold |
182
| – | – | ﹤0.01% | 194 |
|
|
2023
Q2 | $23.1K | Sell |
182
-212
| -54% | -$26.9K | ﹤0.01% | 333 |
|
|
2023
Q1 | $50.9K | Buy |
+394
| New | +$50.9K | 0.01% | 307 |
|
|
2018
Q3 | – | Sell |
-12
| Closed | -$1K | – | 246 |
|
|
2018
Q2 | $1K | Sell |
12
-138
| -92% | -$11.5K | ﹤0.01% | 248 |
|
|
2018
Q1 | $16K | Hold |
150
| – | – | 0.02% | 201 |
|
|
2017
Q4 | $16K | Buy |
+150
| New | +$16K | 0.02% | 202 |
|